Estrogen-Containing Oral Contraceptive Preparations (Ethinylestradiol And Levonorgestrel) has 3 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Lamotrigine, Lamotrigine Extended-Release, Suzetrigine. Patients taking Estrogen-Containing Oral Contraceptive Preparations (Ethinylestradiol And Levonorgestrel) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 1
- Moderate
- 2
Major (1)
- Estrogen-Containing Oral Contraceptive Preparations (Ethinylestradiol And Levonorgestrel) + Lamotrigine— Estrogen-containing oral contraceptives decrease lamotrigine concentrations by approximately 50% and decrease levonorges…
Moderate (2)
- Estrogen-Containing Oral Contraceptive Preparations (Ethinylestradiol And Levonorgestrel) + Lamotrigine Extended-Release— Estrogen-containing oral contraceptives decrease lamotrigine concentrations approximately 50% and decrease levonorgestre…
- Estrogen-Containing Oral Contraceptive Preparations (Ethinylestradiol And Levonorgestrel) + Suzetrigine— Patients using hormonal contraceptives with progestins other than levonorgestrel and norethindrone should use additional…